PIM1 and idiopathic pulmonary fibrosis: Taken together, these data implicate the PIM1 signaling pathway in the sustained activation of profibrotic signals in IPF lungs ex vivo, suggesting that inhibition of this pathway in IPF patients may be an efficacious strategy to promote lung fibroblast quiescence and limit disease progression.